6-Fluoro-o-anisic Acid CAS 137654-21-8 - China Factory, Suppliers, Manufacturers

6-Fluoro-o-anisic Acid CAS 137654-21-8, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

2-Fluoro-6-Methoxybenzoic Acid CAS 137654-21-8 Purity ≥98.5%
Read More

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

(-)-2,3:4,6-Di-O-Isopropylidene-2-Keto-L-Gulonic Acid Monohydrate CAS 68539-16-2 Assay (UV) 98.0~102.0%

Acetobromo-α-D-Glucuronic Acid Methyl Ester CAS 21085-72-3 Assay >95.0% (HPLC)

Trifluoroacetic Acid (TFA) CAS 76-05-1 Purity >99.5% (Titration) Factory

Zoledronic Acid Monohydrate CAS 165800-06-6 Purity ≥99.0% API Factory High Purity

Hyodeoxycholic Acid (HDCA) CAS 83-49-8 Assay 99.0%~101.0%

Top Selling Products

Related Blog
Reviews

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...

2022.12.27 18:42:01
2022.09.29 12:38:11
2022.09.03 10:35:43
2022.03.06 20:20:45
2022.02.02 14:57:22
2021.11.20 19:37:42

6-Fluoro-o-anisic Acid CAS 137654-21-8 - China Factory, Suppliers, Manufacturers

Related Products

2-Fluoro-6-Methoxybenzoic Acid CAS 137654-21-8 Purity ≥98.5%

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

(-)-2,3:4,6-Di-O-Isopropylidene-2-Keto-L-Gulonic Acid Monohydrate CAS 68539-16-2 Assay (UV) 98.0~102.0%

Acetobromo-α-D-Glucuronic Acid Methyl Ester CAS 21085-72-3 Assay >95.0% (HPLC)

Trifluoroacetic Acid (TFA) CAS 76-05-1 Purity >99.5% (Titration) Factory

Zoledronic Acid Monohydrate CAS 165800-06-6 Purity ≥99.0% API Factory High Purity

Hyodeoxycholic Acid (HDCA) CAS 83-49-8 Assay 99.0%~101.0%

Top Selling Products

(S)-2-Hydroxy-3-Methylbutanoic Acid CAS 17407-55-5 Assay ≥98.0% High Purity

H-Pro-OBzl·HCl CAS 16652-71-4 L-Proline Benzyl Ester Hydrochloride Purity >99.0% (HPLC)

Chloromethyl(dichloro)methylsilane CAS 1558-33-4 Purity >99.0% (GC) Factory High Quality

4-Oxo-TEMPO Free Radical CAS 2896-70-0 Purity >95.0% (GC)

Oxalyl Chloride CAS 79-37-8 Purity >99.0% (GC) High Quality

Boc-Cys-OH CAS 20887-95-0 Boc-L-Cysteine Assay 98.5~100.5% (Titration)

4-Nitro-DL-Phenylalanine Hydrate CAS 2922-40-9 Purity >99.0% (HPLC)

Cyclocytidine Hydrochloride CAS 10212-25-6 Purity ≥99.0% (HPLC) Factory High Quality

Fmoc-Arg(Pbf)-OH CAS 154445-77-9 Nα-Fmoc-Nω-Pbf-L-Arginine Purity >99.0% (HPLC) Factory

DIPSO CAS 68399-80-4 Purity >99.0% (Titration) Biological Buffer Ultra Pure Factory

Boc-D-Chg-OH CAS 70491-05-3 Boc-D-Cyclohexylglycine Purity >98.0% (HPLC)

1,1-Bis(Hydroxymethyl)cyclopropane CAS 39590-81-3 Purity >98.0% (GC)

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Xi presents award to top scientists

The “Summit on COVID-19 Diagnostics & Treatment”

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

Paxlovid: what we know about Pfizer's Covid-19 pill

2022.12.27 18:42:01

2022.09.29 12:38:11

2022.09.03 10:35:43

2022.03.06 20:20:45

2022.02.02 14:57:22

2021.11.20 19:37:42

related search